Patrick Y. Wen

发表

Adult precision medicine: learning from the past to enhance the future

Duane A. Mitchell, Wolfgang Wick, Ashley Ghiaseddin, 2020, Neuro-oncology advances.

Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study

Rameen Beroukhim, Rebecca A. Betensky, Tracy T. Batchelor, 2014, Journal of Neuro-Oncology.

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Howard A. Fine, Susan Chang, Frank Lieberman, 2006, Clinical Cancer Research.

Vessel Architectural Imaging Identifies Cancer Patient Responders to Anti-angiogenic Therapy

Bruce R. Rosen, Kim Mouridsen, Percy Ivy, 2013, Nature Medicine.

Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment

Patrick Y. Wen, P. Wen, D. Reardon, 2016, Nature Reviews Neurology.

Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival

Bruce R. Rosen, Ovidiu C. Andronesi, Morteza Esmaeili, 2017, npj Precision Oncology.

Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response

Raymond Y Huang, Patrick Y. Wen, P. Wen, 2015, Front. Neurol..

Individualized screening trial of innovative glioblastoma therapy (INSIGhT).

Lorenzo Trippa, Keith L. Ligon, Brian M. Alexander, 2017 .

NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP

Naoya Hashimoto, Enrico Franceschi, Ashok Panigrahy, 2015 .

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials

Benjamin M. Ellingson, Timothy F. Cloughesy, Patrick Y. Wen, 2017, Neurotherapeutics.

Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab

Lawrence H. Schwartz, Brian M. Alexander, Ken Chang, 2017, Neuro-oncology.

Adaptive platform trials: definition, design, conduct and reporting considerations

Herman Goossens, Donald A. Berry, Lorenzo Trippa, 2019, Nature Reviews Drug Discovery.

Longitudinal MRI evidence for decreased survival among periventricular glioblastoma

Geoffrey S. Young, Joshua D. Lawson, Kian Setayesh, 2010, Journal of Neuro-Oncology.

Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients12

Kamran Paynabar, Jayashree Kalpathy-Cramer, Kourosh Jafari-Khouzani, 2015, Translational oncology.